T1	Participants 63 99	postmenopausal women with osteopenia
T2	Participants 529 654	81 postmenopausal osteopenic women to 1-yr nightly treatment with melatonin 1 mg (N = 20), 3 mg (N = 20), or placebo (N = 41)
